Variables PRE POST Control P1 P2 P3 HCV RNA 103/ml 1143.5 ± 30.02 212.2 ± 73.3 1047.91 ± 80.2 0.047* 0.0001* 0.0001* SGOT IU/ML 46.1 ± 5.29 28.03 ± 2.49 43.8 ± 3.9 0.82 0.0001* 0.0001* SGPT IU/ML 49.79 ± 6.18 28.98 ± 2.74 45.4 ± 2.2 0.83 0.0001* 0.0001* HB %/gm/dL 12.87 ± 0.169 13.8 ± 0.18 16.8 ± 0.33 0.001* 0.001* 0.001* Platelets 103/cm 192.3 ± 7.27 272 ± 14.06 252.2 ± 9.13 0.001* 0.188 0.0001* WBCs/cm 4.89 ± 0.17 6.7 ± 0.26 6.09 ± 0.41 0.0001* 0.341 0.0001* Lymphocyte % 26.36 ± 1.39 36.2 ± 1.49 35.9 ± 2.01 0.0001* 0.555 0.0001* Neutrophil % 47.8 ± 2.08 55.86 ± 1.23 59.0 ± 1.34 0.0001* 0.752 0.0001* Urea mg/dl 30.1 ± 1.3 28.6 ± 1.15 33.6 ± 1.9 0.025 0.056 23.98 Creatinine mg/dl 2.01 ± 0.75 1.49 ± 0.6 1.07 ± 0.65 0.01* 0.0001* 0.009* Blood sugar mg/dl 96.04 ± 3.3 100.98 ± 3.04 103.1 ± 2.1 1.94 2.52 2.2 PRE: Pre-therapy; POST: Post-therapy from three months to two years; P1: compare between PRE and control; P2: compare between POST and control; P3: compare between Pre and Post

Table 1: HCV RNA, Liver Function, CBC, Kidney Function and Blood Sugar for Patients and Controls.

Goto home»